New eye drops aim to heal corneal damage and restore sensation
NCT ID NCT06975748
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests an experimental eye drop called STSP-0902 for people with neurotrophic keratitis, a rare condition where the cornea loses sensation and can develop ulcers. The trial will enroll 48 adults with moderate to severe disease. Participants will receive either the active eye drop or a placebo, applied 3 or 6 times daily for 8 weeks. The main goals are to check safety and see if the drops help heal the cornea and improve eye sensation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
STSP-0902 ophthalmic solution (eye drops)
What this could lead to
If it works, this could provide a new treatment option to heal corneal damage and restore sensation in people with neurotrophic keratitis.
What could go wrong
This is an early Phase 2 trial with only 48 participants, so results may not apply to everyone. The treatment may not work better than placebo, and eye drops can cause irritation or other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROTROPHIC KERATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shandong First Medical University Affiliated Eye Hospital
RECRUITINGJinan, Shandong, 250021, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••